πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

34 results for β€œInsulin” Clear

  1. insulin isophane human

    HUMULIN NPH NovoThirteen

  2. insulin lispro

    HUMALOG

    SUBCUTANEOUS approved

    A10AB04
  3. insulin lispro + insulin lispro protamine

    HUMALOG MIX25 KWIKPEN

  4. insulin lispro protamine recombinant

    HUMALOG MIX 50/50 KWIKPEN

    INJECTION approved

  5. insulin lispro recombinant

    HUMALOG KWIKPEN

    INJECTION approved

  6. insulin lispro-aabc

    LYUMJEV

    INJECTION approved

  7. insulin neutral human

    ACTRAPID NovoThirteen

  8. insulin neutral human + insulin isophane human

    HUMULIN 30/70

  9. insulin recombinant human

    HUMULIN R PEN

    INJECTION approved

  10. insulin susp isophane recombinant human

    HUMULIN N

    INJECTION approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources